Literature DB >> 5099667

In vitro and in vivo activity of a lymphocyte and immune complex-dependent chemotactic factor for eosinophils.

S Cohen, P A Ward.   

Abstract

When cultured in the presence of specific antigen, lymphocytes from delayed-hypersensitive guinea pigs release a number of biologically active substances into the culture medium. Such active supernatants can react with immune complexes in vitro to generate a factor which is chemotactic for eosinophils. The factor involved is unique, since previously described chemotactic factors for other cell types require for their generation either immune complexes or substances released into lymphocyte culture, but not both. In the case of the eosinophil chemotactic factor, the interaction between the substance elaborated by the lymphocytes and the immune complexes appears to be specific in that the immune complexes must contain the same antigen as that used to activate the lymphocyte cultures. Although this factor was generated in an in vitro system, it has been shown to possess in vivo as well as in vitro activity. It is therefore possible that this factor may be of biological significance in situations where eosinophils are participants in inflammatory or immunologic reactions.

Entities:  

Mesh:

Year:  1971        PMID: 5099667      PMCID: PMC2138883          DOI: 10.1084/jem.133.1.133

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  22 in total

1.  Eosinophil leucocytes and their reactions to histamine and 5-hydroxytryptamine.

Authors:  R K ARCHER
Journal:  J Pathol Bacteriol       Date:  1959-07

2.  Further studies on the chemotactic factor of complement and its formation in vivo.

Authors:  P A Ward; C G Cochrane; H J Muller-Eberhard
Journal:  Immunology       Date:  1966-08       Impact factor: 7.397

3.  Chemotaxis of human eosinophils.

Authors:  P A Ward
Journal:  Am J Pathol       Date:  1969-01       Impact factor: 4.307

4.  The immunological specificity of a macrophage inhibition factor.

Authors:  H E Amos; P J Lachmann
Journal:  Immunology       Date:  1970-02       Impact factor: 7.397

5.  Leukotactic factor produced by sensitized lymphocytes.

Authors:  P A Ward; H G Remold; J R David
Journal:  Science       Date:  1969-03-07       Impact factor: 47.728

6.  Mechanism of eosinophilia. II. Role of the lymphocyte.

Authors:  A Basten; P B Beeson
Journal:  J Exp Med       Date:  1970-06-01       Impact factor: 14.307

7.  Mechanism of eosinophilia. I. Factors affecting the eosinophil response of rats to Trichinella spiralis.

Authors:  A Basten; M H Boyer; P B Beeson
Journal:  J Exp Med       Date:  1970-06-01       Impact factor: 14.307

8.  Delayed hypersensitivity. II. Induction of hypersensitivity in guinea pigs by means of antigen-antibody complexes.

Authors:  A M PAPPENHEIMER; S B SALVIN; J W UHR
Journal:  J Exp Med       Date:  1957-01-01       Impact factor: 14.307

9.  Delayed hypersensitivity. III. Specific desensitization of guinea pigs sensitized to protein antigens.

Authors:  J W UHR; A M PAPPENHEIMER
Journal:  J Exp Med       Date:  1958-12-01       Impact factor: 14.307

10.  THE ROLE OF SERUM COMPLEMENT IN CHEMOTAXIS OF LEUKOCYTES IN VITRO.

Authors:  P A WARD; C G COCHRANE; H J MUELLER-EBERHARD
Journal:  J Exp Med       Date:  1965-08-01       Impact factor: 14.307

View more
  43 in total

1.  The mouse thymus in hypoxia and rebound: A histological study.

Authors:  M D Kendall; P Yaffe; J M Yoffey
Journal:  J Anat       Date:  1985-10       Impact factor: 2.610

2.  The cellular infiltrate of the jejunum in adult coeliac disease and dermatitis herpetiformis following the reintroduction of dietary gluten.

Authors:  M Lancaster-Smith; P J Kumar; A M Dawson
Journal:  Gut       Date:  1975-09       Impact factor: 23.059

3.  Eosinophil chemotaxis of supernatants from cultured Hodgkin's lymph node cells.

Authors:  A B Kay; J M McVie; A E Stuart; A Krajewski; L W Turnbull
Journal:  J Clin Pathol       Date:  1975-06       Impact factor: 3.411

4.  Eosinophilopoietin. A circulating low molecular weight peptide-like substance which stimulates the production of eosinophils in mice.

Authors:  A A Mahmoud; M K Stone; R W Kellermeyer
Journal:  J Clin Invest       Date:  1977-09       Impact factor: 14.808

5.  Granulocytes (the red, white, and blue) in hypersensitivity reactions: A review.

Authors:  H F Dvorak; S Cohen; P A Ward
Journal:  Inflammation       Date:  1976-03       Impact factor: 4.092

6.  Disorders of the mononuclear phagocyte system. An analytical review.

Authors:  G Meuret
Journal:  Blut       Date:  1977-04

Review 7.  The role of cell-mediated immunity in the induction of inflammatory responses. Parke-Davis Award Lecture, 1977.

Authors:  S Cohen
Journal:  Am J Pathol       Date:  1977-09       Impact factor: 4.307

8.  Progressive systemic sclerosis-polymyositis overlap syndrome with eosinophilic pleural effusion.

Authors:  Etsuko Maeshima; Takeshi Nishimoto; Mikako Yamashita; Masatoshi Mune; Susumu Yukawa
Journal:  Rheumatol Int       Date:  2003-04-26       Impact factor: 2.631

9.  Antigen-induced eosinophil chemotactic factor (ECF) release by human leukocytes.

Authors:  B M Czarnetzki; W König; L M Lichtenstein
Journal:  Inflammation       Date:  1976-03       Impact factor: 4.092

10.  Mechanism of dinitrochlorobenzene-induced dermatitis in mice: role of specific antibodies in pathogenesis.

Authors:  Elizabeth Yan Zhang; Aaron Yun Chen; Bao Ting Zhu
Journal:  PLoS One       Date:  2009-11-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.